Outcomes of a Bladder Cancer Screening Program Using Home Hematuria Testing and Molecular MarkersChris H. Bangma, Monique J. Roobol, Conja G.A.M. Franken et al.|European Urology|2013Cited by 58
Optimization of Nonmuscle Invasive Bladder Cancer Recurrence Detection Using a Urine Based <i>FGFR3</i> Mutation AssayTahlita C.M. Zuiverloon, Ellen C. Zwarthoff, Stephen S. Tjin et al.|The Journal of Urology|2011Cited by 45
In-depth investigation of the molecular pathogenesis of bladder cancer in a unique 26-year old patient with extensive multifocal disease: a case reportTahlita C.M. Zuiverloon, Ellen C. Zwarthoff, Cheno Abas et al.|BMC Urology|2010Cited by 6
124 FEASIBILITY STUDY OF POPULATION BASED SCREENING FOR BLADDER CANCER WITH URINARY MOLECULAR MARKERS (BLUP) (WWW.BLU-PROJECT.ORG)Monique J. Roobol, C. Bangma, C.G.A.M. Franken-Raab et al.|European Urology Supplements|2009Cited by 2